Benchmark Boosts Plexus (NASDAQ:PLXS) Price Target to $195.00

Plexus (NASDAQ:PLXS) had its price objective increased by stock analysts at Benchmark from $165.00 to $195.00 in a research note issued on Wednesday, Marketbeat Ratings reports. The brokerage presently has a “buy” rating on the technology company’s stock. Benchmark’s price objective suggests a potential downside of 1.32% from the company’s current price.

Several other research analysts have also issued reports on the company. Wall Street Zen lowered Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Needham & Company LLC raised their price target on Plexus from $158.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Sidoti downgraded Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price objective on the stock. in a research report on Friday, October 24th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Plexus in a research note on Thursday, January 22nd. Finally, Stifel Nicolaus set a $150.00 target price on shares of Plexus in a research note on Friday, October 24th. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $171.00.

Plexus Trading Up 9.3%

PLXS stock opened at $197.60 on Wednesday. Plexus has a twelve month low of $103.43 and a twelve month high of $198.76. The stock has a market capitalization of $5.29 billion, a price-to-earnings ratio of 30.73 and a beta of 0.81. The company has a quick ratio of 0.77, a current ratio of 1.58 and a debt-to-equity ratio of 0.06. The firm’s fifty day simple moving average is $158.75 and its two-hundred day simple moving average is $145.40.

Plexus (NASDAQ:PLXS) last released its earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.77 by $0.01. The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.07 billion. Plexus had a net margin of 4.28% and a return on equity of 12.55%. The business’s revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the business earned $1.73 EPS. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. As a group, analysts anticipate that Plexus will post 5.9 earnings per share for the current year.

Insider Activity

In other Plexus news, CAO Angelo Michael Ninivaggi, Jr. sold 1,347 shares of the stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $144.93, for a total transaction of $195,220.71. Following the completion of the sale, the chief accounting officer directly owned 21,544 shares of the company’s stock, valued at approximately $3,122,371.92. This represents a 5.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Patrick John Jermain sold 2,000 shares of Plexus stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $143.53, for a total transaction of $287,060.00. Following the completion of the transaction, the chief financial officer directly owned 16,961 shares in the company, valued at approximately $2,434,412.33. The trade was a 10.55% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 9,674 shares of company stock worth $1,382,876 over the last ninety days. 1.78% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Plexus

Several institutional investors have recently bought and sold shares of the company. Salomon & Ludwin LLC acquired a new position in shares of Plexus during the third quarter worth $30,000. Allworth Financial LP grew its stake in Plexus by 70.1% during the 3rd quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock worth $36,000 after buying an additional 103 shares during the last quarter. Huntington National Bank grew its stake in Plexus by 41.5% during the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after buying an additional 95 shares during the last quarter. Johnson Financial Group Inc. acquired a new position in Plexus during the 3rd quarter valued at about $72,000. Finally, CWM LLC raised its stake in Plexus by 65.7% in the second quarter. CWM LLC now owns 537 shares of the technology company’s stock valued at $73,000 after buying an additional 213 shares during the last quarter. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Q1 results and raised Q2 guidance — Plexus reported fiscal Q1 revenue of $1.07B (≈+10% YoY) and non‑GAAP EPS $1.78, and guided Q2 revenue to $1.110–$1.150B with non‑GAAP EPS $1.80–$1.95, above consensus. Management said momentum could push fiscal 2026 revenue growth above prior targets. Plexus Announces Fiscal First Quarter Financial Results
• Positive Sentiment: Program ramps and market-share gains — Plexus won 22 new manufacturing programs with ~$283M of annualized revenue potential (Aerospace/Defense contributed a record ~$220M), which management says will drive sequential revenue ramps. This underpins the upgraded guidance and growth outlook. Plexus signals potential to exceed 12% revenue growth for fiscal 2026 amid robust market share gains
• Positive Sentiment: Analyst support — After the results, brokers raised and reiterated buy ratings and price targets (Benchmark raised its target; Needham reiterated/maintained bullish views), reinforcing upside expectations. Plexus: Strong Fiscal 2026 Start and Upgraded Outlook Support Raised Buy Rating and $206 Price Target
• Neutral Sentiment: Calls and deeper analysis available — Management hosted an earnings call/transcript and several outlets published Q4/Q1 deep dives that add color on end‑markets (Healthcare/Life Sciences and Aerospace/Defense drove growth) and execution details for program ramps. These provide more context for investors assessing sustainability of growth. PLXS Q4 Deep Dive: Program Ramps and Market Share Gains Drive Guidance Upgrade
• Negative Sentiment: Cash-flow and working-capital drag; insider selling — Q1 produced negative free cash flow (~$50.6M) due to working-capital build for program ramps and higher inventory; GAAP EPS fell sequentially. Quiver/other trackers also show notable insider sales in recent months, which some investors view as a caution. Plexus Corp. Reports Fiscal Q1 2026 Financial Results and Guidance for Q2 2026

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.